dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 20 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 50 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 70 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 80 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 100 mg - dasatinib
dasatinib krka
krka, d.d., novo mesto - dazatinibas - plėvele dengtos tabletės - 140 mg - dasatinib
lenalidomide krka d.d.
krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - imunosupresantai - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) yra nurodytos gydyti suaugusiems pacientams su anksčiau negydytų mieloma, kurie nėra tinkami persodinti. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
dasatinib zentiva
zentiva k.s. - dazatinibas - plėvele dengtos tabletės - 50 mg - dasatinib
dasatinib zentiva
zentiva k.s. - dazatinibas - plėvele dengtos tabletės - 100 mg - dasatinib
skysona
bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - kiti nervų sistemos vaistai - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.